Clinical Trial Detail

NCT ID NCT03344536
Title A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Debio 1347 + Fulvestrant

Age Groups: senior adult

Additional content available in CKB BOOST